Skip to content

Clinical trials

Terminated Kidney Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Kidney Diseases Status: Terminated Clear all

64 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20032
20041
20053
20061
20074
20087
20092
20103
20111
20123
20132
20145
20153
20164
20173
20182
20195
20202
20213
20222
20234

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated64

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Brigham and Women's Hospital4
Celldex Therapeutics3
Amgen2
Aravive, Inc.2
Assistance Publique - Hôpitaux de Paris2
Astellas Pharma Inc2
Goldfinch Bio, Inc.2
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2
Shire2
University of Alabama at Birmingham2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Kidney Diseases64
Renal Insufficiency9
Renal Insufficiency, Chronic9
Kidney Failure, Chronic8
Anemia6
Carcinoma, Renal Cell6
Diabetic Nephropathies6
Kidney Neoplasms6
Acute Kidney Injury5
Diabetes Mellitus5

Trials

Showing 1 to 25 of 64. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.